Defunct Company
Total Trials
11
As Lead Sponsor
As Collaborator
0
Total Enrollment
410
NCT01105403
Exploratory Study on POL6326 in Stem Cell Mobilization
Phase: Phase 2
Role: Lead Sponsor
Start: Apr 30, 2009
Completion: Apr 30, 2014
NCT01841476
Safety and Efficacy of POL6326 for Mobilization of Hematopoietic Stem Cells in Healthy Volunteers
Phase: Phase 1
Start: Feb 29, 2012
Completion: Sep 30, 2015
NCT01413568
Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic Malignancies
Phase: Phase 1/2
Start: Apr 30, 2012
Completion: Dec 31, 2015
NCT02110459
Pharmacokinetics and Safety of POL7080 in Patients With Renal Impairment
Start: Apr 30, 2013
Completion: Jul 31, 2015
NCT01837095
Dose Escalation of POL6326 in Combination With Eribulin in Patients With Metastatic Breast Cancer
Start: Jun 30, 2013
Completion: Aug 31, 2018
NCT01905475
CXCR4 Antagonism for Cell Mobilisation and Healing in Acute Myocardial Infarction (CATCH-AMI)
Start: Jul 31, 2013
Completion: Jun 30, 2016
NCT02096328
Pharmacokinetics, Safety and Efficacy of POL7080 in Patients With Ventilator Associated Pseudomonas Aeruginosa Pneumonia
Start: Oct 31, 2013
Completion: Dec 31, 2016
NCT02096315
Safety, Efficacy and PK/PD of POL7080 in Patients With Exacerbation of Non-cystic Fibrosis Bronchiectasis.
Start: Dec 31, 2013
Completion: Nov 30, 2015
NCT02897869
DDI Study to Investigate Interaction Between Amikacin and POL7080
Start: Apr 30, 2016
NCT03409679
Pivotal Study in VAP Suspected or Confirmed to be Due to Pseudomonas Aeruginosa
Phase: Phase 3
Start: Mar 23, 2018
Completion: Jul 17, 2019
NCT03582007
Pivotal Study in Nosocomial Pneumonia Suspected or Confirmed to be Due to Pseudomonas
Start: Oct 22, 2018